Source document or public record

FDA 510(k) K214122 — BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel

FDA 510(k) index record K214122. Device: BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel. Applicant as listed: Becton, Dickinson and Company. Decision date: 2022-07-28.

OtherU.S. Food and Drug Administration (FDA)2022-07-28

Source

"device_name": "BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K214122.

Device name: BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel. Applicant as listed: Becton, Dickinson and Company.

Decision date: 2022-07-28. Decision wording: Substantially Equivalent.

Product code: PCI. Regulation: 21 CFR 866.3990. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.